Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-03 Carvajal Alejandra Chief Legal Officer Grant or award +100,000 100,000
2026-08-03 Carvajal Alejandra Chief Legal Officer Grant or award · Stock Option (Right to Buy) +450,000 450,000
2026-07-24 Fuchs Charles S. Director Grant or award · Stock Option (Right to Buy) +118,000 118,000
2026-06-17 Su Zhen Director Grant or award · Stock Option (Right to Buy) +59,000 59,000
2026-06-17 Young Matthew P. Director Grant or award · Stock Option (Right to Buy) +59,000 59,000
2026-06-17 Mohindru Mani Director Grant or award · Stock Option (Right to Buy) +59,000 59,000
2026-06-17 Meyers James R Director Grant or award · Stock Option (Right to Buy) +59,000 59,000
2026-06-17 Gilbert Halley E Director Grant or award · Stock Option (Right to Buy) +59,000 59,000
2026-06-17 Ashworth Alan Director Grant or award · Stock Option (Right to Buy) +59,000 59,000
2026-06-17 Jones Elaine V Director Grant or award · Stock Option (Right to Buy) +59,000 59,000
2026-06-15 Ogden Christopher Chief Financial Officer Sale −1,624 $3.05 $5K 295,324
2026-03-17 Chu Yu-Waye Chief Medical Officer Sale −21,279 $6.42 $137K 189,446
2026-03-17 McCarthy Sean A. CEO Sale 10b5-1 −118,969 $6.42 $764K 1,078,922
2026-03-17 BELVIN MARCIA SVP, Chief Scientific Officer Sale −31,492 $6.42 $202K 300,760
2026-03-17 Ogden Christopher Chief Financial Officer Sale −19,323 $6.42 $124K 296,948
2026-02-02 Lester Rachael Chief Business Officer Grant or award +20,000 20,000
2026-02-02 Lester Rachael Chief Business Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2026-02-02 Lester Rachael Chief Business Officer Grant or award · Performance Stock Units (PSUs) +50,000 50,000
2026-02-02 Chu Yu-Waye Chief Medical Officer Grant or award +75,000 210,725
2026-02-02 Chu Yu-Waye Chief Medical Officer Grant or award · Stock Option (Right to Buy) +300,000 300,000

Page 1 of 33 · 649 trades